Item 8.01 Other Events.

On May 27, 2022, Instil Bio, Inc. (the "Company") issued a press release entitled "Instil Bio Announces IND Clearance of First CoStAR-TIL program, ITIL-306, Designed To Enhance Activity in the Tumor Microenvironment" The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.



(d)   Exhibits



 Exhibit No.       Description
     99.1            Press release, dated May 27, 2022.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses